D H Ho
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
Papers in
-
- Antibiotic Resistance in Bacteria 19
- Co-authors
- Emil FreiGerald P. BodeyBarbara LeBlancN BrownMichael J. KeatingRobert A. NewmanRichard PazdurBenjamin Drewinko
- Journals
- Antimicrobial Agents and Chemotherapy (18 papers)Drug Metabolism and Disposition (7 papers)Clinical Pharmacology & Therapeutics (6 papers)Biochemical Pharmacology (6 papers)Chemotherapy (5 papers)
- Partner nations
- United StatesJapanRussia
In The Last Decade
D H Ho
99 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 112
- Molecular Medicine 273
- Oncology 768
- Pharmacology 405
- Clinical Biochemistry 160
- Endocrinology 90
Countries citing papers authored by D H Ho
This map shows the geographic impact of D H Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D H Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D H Ho more than expected).
Fields of papers citing papers by D H Ho
This network shows the impact of papers produced by D H Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D H Ho. The network helps show where D H Ho may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D H Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 35 | |
| 2 | 2003 | 22 | |
| 3 | 2002 | 12 | |
| 4 | 2000 | 18 | |
| 5 | 1999 | 39 | |
| 6 | 1998 | 33 | |
| 7 | 1996 | 56 | |
| 8 | 1996 | 47 | |
| 9 | 1993 | 166 | |
| 10 | 1992 | 18 | |
| 11 | 1988 | 2 | |
| 12 | 1988 | 3 | |
| 13 | 1988 | 20 | |
| 14 | 1986 | 11 | |
| 15 | 1986 | 11 | |
| 16 | Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells. | 1980 | 13 |
| 17 | Pharmacological disposition of tetrahydrouridine in man | 1977 | 1 |
| 18 | Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosine. | 1977 | 8 |
| 19 | 1975 | 13 | |
| 20 | Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma. | 1972 | 22 |
About D H Ho
D H Ho is a scholar working on Drug Discovery, Molecular Medicine, Pharmacology, Oncology and Clinical Biochemistry, having authored 100 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Neutropenia and Cancer Infections (20 papers), Antibiotic Resistance in Bacteria (19 papers), Cancer therapeutics and mechanisms (18 papers), Biochemical and Molecular Research (16 papers), Acute Lymphoblastic Leukemia research (11 papers), HIV/AIDS drug development and treatment (10 papers) and Colorectal Cancer Treatments and Studies (7 papers). The work is most often cited by research in Molecular Medicine (273 citations), Oncology (768 citations), Pharmacology (405 citations), Clinical Biochemistry (160 citations) and Endocrinology (90 citations). D H Ho has collaborated with scholars based in United States, Japan and Russia. Frequent co-authors include Emil Frei, Gerald P. Bodey, Barbara LeBlanc, N Brown, Michael J. Keating, Robert A. Newman, Richard Pazdur, Benjamin Drewinko, Yvonne Lassere and Susan Lerner. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Biochemical Pharmacology and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.